Niantong Intelligence Secures Tens of Millions in Pre-A Financing to Accelerate BCI Product Commercialization

VCBeat has learned that Shanghai Niantong Intelligent Technology Co., Ltd. (abbreviated as "NIANTONG INTELLIGENCE") recently completed a Pre-A financing round worth tens of millions of RMB, led by Liuhe Ventures and participated in by Yili Wanwei. The proceeds from this round will primarily be used to accelerate the R&D and clinical registration of the company's brain-computer interface (BCI) products, expedite the commercialization of BCI technology, and drive the rapid development of brain science research.

Shanghai Niantong Intelligent Technology Co., Ltd., incubated at Shanghai Jiao Tong University in 2016, is a high-tech enterprise specializing in the research and development of electroencephalogram (EEG) and related technologies. Leveraging over a decade of technological accumulation and expertise from Shanghai Jiao Tong University, the company integrates scientific research, development, production, sales, and technical services,Dedicated to the R&D and commercialization of products related to EEG, EMG, near-infrared spectroscopy, electrical stimulation, and other technologies, providing professional technical solutions for the fields of brain science, rehabilitation medicine, neurological diagnosis, and human factors engineering.

The company has engaged in in-depth collaboration with Shanghai Jiao Tong University and Huashan Hospital, Fudan University, and has researched and developed solutions targeting stroke patients,eCon-Hand Brain-Controlled Exoskeleton Rehabilitation Training System.

eCon-Hand consists of an EEG helmet and an exoskeleton robotic hand,The EEG helmet is responsible for EEG signal acquisition and real-time decoding, while the exoskeleton robotic hand assists the patient's affected hand in grasp or extension training based on EEG commands.The eCon-Hand Rehabilitation System features a wearable design, offering comfortable wear and easy operation. With the assistance of the system, patients canUsing one's own EEG signals to control the affected limb for active rehabilitation training.

According to Hebbian theory, the repeated pairing of central neural excitation with external stimuli can enhance synaptic transmission efficacy, thereby promoting functional brain remodeling in stroke patients. Numerous RCTs have demonstrated that,eCon-Hand is used for hand function rehabilitation training in chronic stroke patients and can effectively improve their recovery outcomes.The proceeds from this financing round will primarily be allocated to the product registration and market promotion of the eCon-Hand rehabilitation training system, as well as the iterative development and upgrades of subsequent products.

Brain-computer interface (BCI) technology is one of the key research directions in the global field of brain science, holding significant application value in neurorehabilitation, neural regulation, human factors engineering, and the diagnosis of brain diseases. In the recently released guidelines for the “Science and Technology Innovation 2030 – Brain Science and Brain-Inspired Research” major project, BCI technology is prominently featured. This research initiative will allocate a total of 3.148 billion RMB to support the exploration of cutting-edge technologies and the translation of research outcomes into practical applications.

Moving forward, NIANTONG INTELLIGENCE will continue to deepen its focus on the brain-computer interface (BCI) field, continuously developing new BCI products to deliver advanced technologies and products to a broad consumer base.

Founded in 2008, Liuhe Capital is one of the earliest registered members of the Asset Management Association of China (AMAC). The firm primarily specializes in the innovative and intelligent high-end manufacturing sector, with a strategic focus on advanced equipment, innovative materials, and data intelligence. It is committed to discovering, investing in, and serving Chinese technology innovation enterprises within this field that possess ambitious development goals. To date, it has cumulatively invested in over 40 projects, with notable portfolio companies including: DR Laser (300776.SZ), Huarui Precision (688059.SH), Huace Media (300133.SZ), Xuerong Biotechnology (300511.SZ), Huayuan Computing, Yunzhangfang, JoinQuant, Meixin Finance, and Yuanben.